Satellos Bioscience Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 |
|---|---|---|
| Operating Activities | ||
| Net Income | $-24.9M | $-20.6M |
| Depreciation & Amortization | — | — |
| Depreciation | — | — |
| Amortization | — | — |
| Stock-Based Compensation | — | — |
| Net Cash from Operating Activities | $-23.6M | $-18.3M |
| Investing Activities | ||
| Capital Expenditures | $6.0K | $4.0K |
| Business Acquisitions | — | — |
| Net Cash from Investing Activities | $-9.4M | $4.7M |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | — | — |
| Net Cash from Financing Activities | $2.2M | $37.6M |
| Net Change in Cash | $-30.3M | $23.4M |
| Free Cash Flow | $-23.6M | $-18.3M |